KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) EBT (2018 - 2025)

Historic EBT for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$5.9 million.

  • ClearPoint Neuro's EBT fell 1860.89% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.4 million, marking a year-over-year decrease of 2837.27%. This contributed to the annual value of -$19.7 million for FY2024, which is 1202.89% up from last year.
  • According to the latest figures from Q3 2025, ClearPoint Neuro's EBT is -$5.9 million, which was down 1860.89% from -$5.8 million recorded in Q2 2025.
  • ClearPoint Neuro's EBT's 5-year high stood at -$2.5 million during Q1 2021, with a 5-year trough of -$7.1 million in Q2 2023.
  • Its 5-year average for EBT is -$4.7 million, with a median of -$4.5 million in 2022.
  • Per our database at Business Quant, ClearPoint Neuro's EBT plummeted by 15829.39% in 2021 and then skyrocketed by 3839.57% in 2024.
  • ClearPoint Neuro's EBT (Quarter) stood at -$4.0 million in 2021, then decreased by 12.23% to -$4.5 million in 2022, then fell by 5.3% to -$4.7 million in 2023, then fell by 20.02% to -$5.6 million in 2024, then decreased by 4.16% to -$5.9 million in 2025.
  • Its last three reported values are -$5.9 million in Q3 2025, -$5.8 million for Q2 2025, and -$6.0 million during Q1 2025.